ASBP Stock Summary and Trading Ideas (Aspire Biopharma Holdings | NASDAQ:ASBP)

Aspire Biopharma Holdings Inc is an early-stage biopharmaceutical company focused on developing and commercializing novel sublingual drug delivery technologies. The company is mainly engaged in advancing patent-pending formulations designed to enable rapid absorption of drugs, initially targeting high-dose aspirin products for cardiovascular and pain management applications. Its technology aims to improve efficacy and response time by bypassing the gastrointestinal tract through sublingual delivery.

Aspire Biopharma Holdings trades on the NASDAQ stock market under the symbol ASBP.

As of April 10, 2026, ASBP stock price declined to $1.06 with 64,545 million shares trading.

ASBP has a beta of 1.54, meaning it tends to be more sensitive to market movements. ASBP has a correlation of 0.02 to the broad based SPY ETF.

ASBP has a market cap of $5.33 million. This is considered a Sub-Micro Cap stock.

The top ETF exchange traded funds that ASBP belongs to (by Net Assets): VXF.

ASBP has underperformed the market in the last year with a return of -95.0%, while the SPY ETF gained +30.9%. In the last 3 month period, ASBP fell short of the market, returning -74.5%, while SPY returned -1.8%. However, in the most recent 2 weeks ASBP has outperformed the stock market by returning +16.1%, while SPY returned +7.2%.

ASBP support price is $1.04 and resistance is $1.36 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ASBP shares will trade within this expected range on the day.